GE's restructuring could mean upside for share price. Strategies Raising cash and looking for smart trades
Intel and Teva may be close to deals that will bolster revenue outlook. Strategies Intel and Teva are on the prowl for deals
Mergers are driving up biotech stocks, but beware of short traders. Outlook Biotech stocks? Proceed with caution
Energy price declines have created a buying opportunity in solar. Outlook Strategies The sunny outlook for First Solar
Here's why I'm building up cash and waiting for opportunities. Strategies Searching for value isn’t easy in this market
Energy, tech and finance trends will shape the U.S. economic outlook. Outlook Investing sectors to watch in 2015
October's market turmoil required quick foot work. Strategies How I traded through October’s wild market swings
Ford, GE and Intel still look attractive in this choppy market. Strategies Why Ford still shines despite stock market rout
Middle classes in China and India seek better healthcare. Strategies Global demand is lifting healthcare
There is a lot of churn and rotation driving this stock market. Strategies The market is heading higher but beware of a pullback
A big cash position is an edge in this market. Strategies Why we have a 35% cash position in this market
Troubles in Europe opened the way for our purchase of the French drug company. Strategies Why we added Sanofi Aventis, Halliburton and Western Union to …
